SECOND WHO CONSULTATION ON A GLOBAL ACTION PLAN FOR

15 July 2011

1

SECOND WHO CONSULTATION ON

A GLOBAL ACTION PLAN FOR INFLUENZA VACCINES

12 - 14 July 2011, Geneva, Switzerland, WHO Headquarters

FINAL LIST OF PARTICIPANTS

Professor Jon Abramson Professor and Chair

Pediatrics

Wake Forest University Baptist Medical Center

27157 Winston-Salem

United States of America

Dr Carmen Amela Director General for Public Health and Foreign Health

Ministry of Health, Social Policy and Equality

28071 Madrid

Spain

Professor Ashraf Bayoumi Head

Central Administration of Pharmaceutical Affairs

Egyptian Drug Authority

Cairo, Egypt

Dr Martin Bachmann Chief Scientific Officer

Cytos Biotechnology AG

Wagistrasse 25

8592 Schlieren

Switzerland

Dr David Behnam Pandemic Preparedness Initiative, Division for Health, Education, Social Protection

Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH

65726 Eschborn

Germany

15 July 2011

2

Mr Simeon Bennett Health and Science Reporter

Bloomberg News

1204 Geneva

Switzerland

Dr Cornelia Betsch Scientific Manager

Center of Empirical Research in Economics and Behavioral Sciences

University of Erfurt

Nordhäuser Str. 63

99089 Erfurt

Germany

Dr John Boslego Director

Vaccine Development Global Program

PATH

20001 Washington


Dr Rick A. Bright Acting Chief, Antivirals Advanced Development

International Program Lead

Influenza Division, Office of the Director

Biomedical Advanced Research and Development Authority (BARDA)

US Department of Health and Human Services (HHS)

DHHS/OS/ASPR/BARDA

330 Independence Ave, SW RM G640

Washington, DC 20201

Professor Harry Campbell Centre for Population Health Sciences

University of Edinburgh

EH89AG Edinburgh

United Kingdom of Great Britain and Northern Ireland

Professor Daniel Camus Chargé de mission Grippe, Délégation interministérielle à la Lutte contre la Grippe aviaire

(Service du Premier Ministre)

DILGA

Ministère de la Santé et des Sports

75350 Paris

France

15 July 2011

3

Dr Ze Chen Assistant General Director, Influenza Expert

Shanghai Institute of Biological Products

200052 Shanghai

The People's Republic of China

Ms Malinee Chittaganpitch Medical Scientist

National Institute of Health

11000 Nonthaburi

Thailand

Professor Klaus Cichutek President

Paul-Ehrlich-Institut

63225 Langen

Germany

Dr Kathleen L. Coelingh Senior Director

Medical & Scientific Affairs

MedImmune Advancing Science for Better Health

MedImmune Inc.

94111 San Francisco


Dr Nicolas Collin Head

Vaccine Formulation Laboratory

University of Lausanne

1066 Epalinges sur Lausanne

Switzerland

Dr Manon Cox President and CEO

Protein Sciences Corporation

06450 Meriden


Dr Nancy J. Cox Director of Influenza Division, National Center for Immunization and Respiratory Diseases

National Center for Infectious Diseases, Centers for Disease Control and Prevention

GA 30333 Atlanta


15 July 2011

4

Dr William Cracknell Senior Technical Advisor

Global Influenza

CSL Biotherapies

3052 Parkville

Australia

Professor Abdolhossein Dalimi Director General

Razi Vaccine & Serum Research Institute

Karaj

Islamic Republic of Iran

Dr Giuseppe Del Giudice Head Translation Medicine

Novartis Vaccines

Novartis Vaccines and Diagnostics S.p.A, Divisione Biologici et Farmaceutici

Siena

Italy

Dr Rajeev M. Dhere Sr. Director, Vaccine Production

Vaccine Department

Serum Institute of India Ltd.

411 028 Pune

India

Mr Toon Digneffe Director

Government Affairs & Public Policy

Baxter

1420 Braine L'Alleud

Belgium

Dr Daria Donati Core team leader

GE Healthcare

75184 Uppsala

Sweden

Ms Thea Emmerling First Counsellor

Permanent Delegation of the EU to the International Organizations in Geneva

Rue du Grand Pré 66

1211 Geneva

Switzerland

15 July 2011

5

Dr Othmar Engelhardt Principal Scientist

Division of Virology

National Institute for Biological Standards and Control

EN6 3QG Hertfordshire


Dr Harvey Fineberg President

Institute of Medicine

20001 Washington


Dr Donald P. Francis Executive Director

Global Solutions for Infectious Diseases

94080 South San Francisco


Dr Carlos Franco-Paredes Infectious Disease Consultant

Phoebe Putney Memorial Hospital

31721 Albany


Dr Mohammed Gheisarzadeh Technical Officer

Food and Drug Control

Ministry of Health and Medical Education (MOHME)

Fakher Razi Street

Tehran

Islamic Republic of Iran

Dr Bruce Gellin Deputy Asst. Secretary for Health

National Vaccine Program Office

Department of Health and Human Services

20201 Washington


Mr Eduard Geuns Director

Regulatory Affairs

Abbott Biologicals B.V.

NL-1380 DA WEESP

The Netherlands

15 July 2011

6

Dr Jill Glasspool-Malone Consultant

RW Malone MD, LLC.

30143 Jasper


Dr Gary Grohmann Director, Immunobiology & Manager of Prescription Medicines

Office of Laboratories and Scientific Services

Therapeutic Goods Administration

2606 Woden

Australia

Dr Ian Gust Professorial Fellow

Department of Microbiology and Immunology

The University of Melbourne

3010 Melbourne

Australia

Dr Doan Ngoc Hai Secretary for Vice Minister of Health Dr. Nguyen Thi Kim Tien

Ministry Office

Ministry of Health

Hanoi

Viet Nam

Professor Frederick Hayden Influenza Research Coordinator

International activities-Science Funding

The Wellcome Trust

NW1 2BE London


Dr Norbert Hehme Vice President

Global External Relations

GSK Biologicals

01069 Dresden

Germany

Dr Jan T. Hendriks Account Manager

International Support

National Institute for Public Health and Environment (RIVM)

NL-3720 AL Bilthoven

The Netherlands

15 July 2011

7

Dr Nurma Hidayati Head

Sub Directorate of New Product Evaluation

National Agency of Drug and Food Control

10560 Jakarta Pusat

Indonesia

Dr Le Kim Hoa Vice Director, QC & QA, R&D/Head of QA

Institute of Vaccine and Medical Biologicals

Khanh Hoa Province

Viet Nam

Mrs Althea House Chief, Non-Pharmaceutical Intervention

Pandemic Preparedness

Public Health Agency of Canada

K1A 0K9 Ottawa

Canada

Ms Patcha Incomserb Medical Scientist

Department of Medical Sciences

MOPH

Thailand

11000 Nonthaburi

Thailand

Dr Makiyo Iwata International Affairs Division

Ministry of Health, Labour and Welfare

Tokyo

Japan

Dr Suresh Jadhav Executive Director

Quality Assurance & Regulatory Affairs

Serum Institute of India Ltd.

411028 Pune

India

Dr Istvan Jankovics National Center For Epidemiology

1097 Budapest

Hungary

15 July 2011

8

Mr Andrew Jenner Director

IFPMA (International Federation of Pharmaceutical Manufacturers & Associations)

15, chemin Louis-Dunant

P.O. Box 195

1211 Geneva

Switzerland

Dr Seog-Youn Kang Director, Biologics Division

Biopharmaceuticals & Herbal Medicine Evaluation Department

Korean Food and Drug Administration

Seoul

Republic of Korea

Dr Ruth Karron Professor

Center for Immunization Research, Dept of International Health

Johns Hopkins Bloomberg School of Public Health

21205 Baltimore


Mr Ken Kelley CEO

PaxVax

94025 Menlo Park


Mr Sjirk Kok General Manager

Abbott

1381 CP Weesp

The Netherlands

Dr Xavier Kurz Pharmacovigilance, Safety and Efficacy of

Medicines

European Medicines Agency

7 Westferry Circus

Canary Wharf

London, E14 4HB

UK

15 July 2011

9

Dr Rosanna Lagos Coordinadora

Centro para vacunas en Desarollo-Chile

Hospital de Niños Roberto del Rio

Santiago

Chile

Mr Axel Lambert de Rouvroit Managing Partner, Public Safety

Health Security Associates

77930 Fleury-en-Biere

France

Mr Peter Latham President

Latham BioPharm Group

01754 Maynard


Dr Patrick Le Courtois Head, Human Medicines Development and

Evaluation

European Medicines Agency

7 Westferry Circus,

Canary Wharf,

London, E14 4HB

UK

Dr Vernon Lee Adjunct Associate Professor

Department of Epidemiology and Public Health

Yong Loo Lin School of Medicine

National University of Singapore

Singapore

Mr Olivier Loeillot Head of Enterprise Solutions

Life Sciences, GE Healthcare

68300 Saint Louis

France

Professor Johannes Lower Former Director

Paul-Ehrlich-Institut

D-63225 Langen

Germany

15 July 2011

10

Dr Robert Malone Consultant

RW Malone MD, LLC.

30143 Jasper


Dr Maria Julia Marinissen Director

Office of Policy and Planning, Division of International Health Security

U.S. Department of Health and Human Services

20201 Washington


Dr José Ricardo Pio Marins Ministry of Health

SCS Quadra 4 bloco A unidade 4 , 4 andar, Coordenação Geral de Doenças Transmissíveis,

Edifício Principal. Code 70.304-000

74304000 Brasília-DF, Federal District

Brazil

Mr John Mashulski Sales Leader Enterprise Solutions

Life Sciences, GE Healthcare

099253 Singapore

Singapore

Dr James Matthews Vice President

Health & Science Policy

Sanofi Pasteur Inc.

20004 Washington DC


Dr Maggie Habib Meawad OES - Office of International Health and Biodefense

U.S. Department of State

2201 C Street, NW | Washington, DC 20520

Dr Karen Midthun Director

Center for Biologics Evaluation and Research (CBER)

Food and Drug Administration (FDA)

20852 Bethesda MD


15 July 2011

11

Dr Daniel Miller Director, Intl Influenza Unit

US Dept of Health and Human Services

20201 Washington


Professor Elizabeth Miller Advisor

Consultant Epidemiologist

Immunization, Hepatitis and Blood Safety

Health Protection Agency, Centre for Infections

NW9 5EQ London


Dr Rajiv Modi Managing Director

Cadila Pharmaceuticals Ltd

382210 Ahmedabad

India

Dr Arnold Monto The Thomas Francis Jr. Professor

Epidemiology

The University of Michigan School of Public Health

MI 48109-2029 Ann Arbor


Dr Harish Nair Research Fellow

Centre for Population Health Sciences

The University of Edinburgh

EH8 9AG Edinburgh


Dr Abdulsalami Nasidi EchiTAb Study Group, Nigeria

No 18, Arochukwu Street

Garki 2, Abuja

Nigeria

Dr Elisabeth Neumeier GlaxoSmithKline Biologicals

01069 Dresden

Germany

15 July 2011

12

Dr Kathleen Neuzil PATH

2201 Westlake Ave.

Suite 200

98121 Seattle, WA


Professor Angus Nicoll Senior Expert - Influenza Coordination

European Centre for Disease Prevention and Control (ECDC)

Tomtebodavagen 11A

17183, Stockholm

Sweden

Mrs Petronellar Nyagura Resource person

Counsellor

Health

Permanent Mission of the Republic of Zimbabwe to the

United Nations Office and International Organizations at Geneva

1292 Chambésy

Switzerland

Mr Frédéric Ors Vice-President

Business Development

Medicago inc.

G1V 3V9 Quebec

Canada

Dr Albert Osterhaus Head of the Department of Virology, Erasmus University

Rotterdam 3015 GE

The Netherlands

Dr Bram Palache Director, Global Government Affairs

Global Government Affairs

Abbott

1381 CP Weesp

The Netherlands

Ms Catherine Patterson Health Attaché

The Permanent Mission of Australia to the United Nations Office and

Other International Organizations at Geneva

1040 Brussels

Belgium

15 July 2011

13

Dr Michael Perdue Director, Division of Influenza & Emerging Diseases

Biomedical Advanced Research & Development Authority (BARDA)


20201 Washington DC


Dr Samuel Ponce de Leon General Director

Laboratorios de Biologicos y Reactivos de Mexico, S.A. de C.V

06000 DF Mexico

Mexico

Mr Kittisak Poopipatpol Influenza Plant Manager

Biological Products

Government Pharmaceutical Organization

10400 Bangkok

Thailand

Dr Firdausi Qadri Senior Scientist and Head

Immunology Laboratory

ICDDR,B

68, Shaheed Tajuddin Ahmed Sarani

Mohakhali, Dhaka-1212

Bangladesh

Dr Barbara Raymond Director

Pandemic Preparedness

Public Health Agency of Canada

K1A 0K9 Ottawa

Canada

Professor K. Srinath Reddy President

Public Health Foundation of India

110016 New Delhi

India

Dr Daniel Reynders Head of Service

International Relations

FPS Health, Food Chain Safety and Environment

1060 Brussels

Belgium

15 July 2011

14

Dr Byung Geon Rhee President

Green Cross Corporation

446-770 Yongin

Republic of Korea

Dr James S. Robertson Principal Scientist

Virology

National Institute for Biological Standards and Control (NIBSC)

EN6 3QG Potters bar


Dr Robin A. Robinson ASPR Deputy Assistant Secretary and BARDA Director

Office of Biomedical Advanced Research & Development Authority (BARDA)


20201 Washington DC


Mr Nabil Safrany European Commission

2920 Luxemburg

Luxemburg

Dr Vilma Savy Head Respiratory Virus Laboratory

Virology

National Influenza Centre - Instituto C.G. Malbran Salud (ANLIS)

1281 Buenos Aires

Argentina

Dr Pathom Sawanpanyalert Deputy Director General


Ministry of Public Health Thailand

11000 Muang, Nonthaburi

Thailand

Dr Kristine Sheedy Associate Director for Communication Science

National Center for Immunization and Respiratory Diseases

Centers for Disease Control and Prevention

30333 Atlanta


15 July 2011

15

Ms Jane Shepard Baxter AG

A-1221 Vienna

Austria

Dr Rumondang Simanjuntak Head of Sub Directorate of Inspection and Certification of Therapeutic and Household Products


10560 Jakarta Selatan

Indonesia

Dr Surinder Singh Drug Controller General (India)

Central Drugs Standard Control Organization

Ministry of Health & Family Welfare

New Delhi

India

Dr Jaspal Sokhey Consultant in Vaccinology,

Ex Director CRI, Kasauli (HP),

New Delhi

Professor Raymond E. Spier Editor-in-Chief

Vaccine Series Elsevier

EX1 2AH Exeter, Devonshire


Dr Philippe Saudan VP Research

Cytos Biotechnology AG

Wagistrasse 25

8952 Schlieren

Switzerland

Dr Klaus Stohr Vice President

Global Head - Influenza Franchises

Novartis Vaccines and Diagnostics

02113 Cambridge


15 July 2011

16

Dr Mahendra Suhardono Production Director

Bio Farma

40161 Bandung

Indonesia

Dr Miodrag Stamenkovic Medicines and Medical Devices Agency of Serbia,

Ulofa Palmea 26

1000 Belgrade

Serbia

Dr Teiji Takei Director, International Cooperation Office

International Affairs Division

Ministry of Health, Labour and Welfare

100-8916 Tokyo

Japan

Dr Masato Tashiro Director

Influenza Virus Research Center

WHO Collaborating Center for Reference and Reserch on Influenza, National Institute of

Infectious Diseases, Tokyo

208-0011 Tokyo

Japan

Mrs Prapassorn Thanaphollert (Tim) Head of Biological Products Section

Bureau of Drug Control

Food and Drug Administration

11000 Nonthaburi

Thailand

Dr Sit Thirapakpoomanunt Director of the Viral Division

Biological Product

The Government Pharmaceutical Organization

10400 Bangkok

Thailand

Mr Patrick Tippoo R&D Manager

Biovac Institute

7430 Pinelands

South Africa

15 July 2011

17

Professor Oyewale Tomori Vice Chancellor

Department of Microbiology

Redeemer's University

3005 Redemption City

Nigeria

Mr Bill Turner Head

Office of Manufacturing and Quality

TGA

PO Box 100 Woden ACT 2006

Dr Chu Dang Trung Director, Legislation and International Integration Division

Drug Administration of Vietnam

Ministry of Health

Hanoi

Viet Nam

Dr Vadim Tsvetnitsky Vaccine Development Global Program

Program for Appropriate Technology in Health

20001 Washington DC


Dr Dori Ugiyadi Senior Manager for Viral Vaccine Production

Bio Farma

40161 Bandung 40161

Indonesia

Mr Federico Vigano Global Commercial Director, Flu Portfolio

Glaxosmithkline Biologicals

Rixensart

Belgium

Dr Ildiko Visontai Deputy Director

National Center For Epidemiology

1097 Budapest

Hungary

15 July 2011

18

Ms Hui Wang Assistant General Manager

Beijing Tiantan Biological Products Co., Ltd.

100024 Beijing


Mr Michael Wanner Vice-President

US Operations

Medicago inc.

G1V 3V9 Quebec

Canada

Dr Michael Watson IFPMA, B&V Chair

Vice President

Global Immunisation Policy

Sanofi Pasteur

69367 Lyon Cedex 7

France

Dr Bruce G. Weniger Associate Editor

Vaccine (Elsevier)

30345 Atlanta


Dr Emelia Dwiyanti Wibowo Head Secretary of Production Directorate

Production Directorate

Bio Farma

40161 Bandung

Indonesia

Dr Suwit Wibulpolprasert Senior Advisor on Disease Control

Office of Permanent Secretary

Ministry of Public Health

11000 Nonthaburi

Thailand

Dr Ponthip Wirachwong Head of Medical Sciences Research Group

Research and Development Institute

Government Pharmaceutical Organization

10400 Bangkok

Thailand

15 July 2011

19

Mrs Sara Wongjaroen Department of Medical Sciences

MOPH

11000 Nonthaburi

Thailand

Mr Sathaporn Wongjaroen Director General


MOPH

11000 Nonthaburi

Thailand

Dr Endang Woro Director

Directorate of Drug and Biological Product Evaluation


10570 Jakarta Pusat

Indonesia

Mrs Assmaa Yousry Head

Biologicals Product Registration Department

Central Administration for Pharmaceutical Affairs

Egyptian Drug Authority

+202 Cairo

Egypt

Dr Hongjie Yu Deputy Director

Office for Disease Control and Emergency Response

Chinese Center for Disease Control & Prevention

102206 Beijing


Professor Maria Zambon Director, Reference Microbiology Services

Health Protection Agency

NW9 5EQ London


Professor Hamdallah H. Zedan Chairman & CEO of EGYVAC

The Egyptian Organization for Biological Products and Vaccines (Vacsera)

Dokki Giza

Egypt

15 July 2011

20

Dr Christian Zidorn Scientific Officer, DG Research and Innovation

Health Research / Infectious diseases

European Commission

B-1050 Brussels

Belgium

WHO SECRETARIAT Dr Claudia Alfonso Scientist

Immunization, Vaccines and Biologicals/Quality, Safety and Standards (IVB/QSS)

Headquarters, Geneva, Switzerland

Ms Angela Baffoe Administration Assistant

Immunization, Vaccines and Biologicals /Initiative for Vaccine Research (IVB/IVR)


Ms Florence Barthelemy Administration Assistant

Innovation, Information, Evidence and Research (IER)


Ms Janna Breteler Intern



Dr Flavia Bustreo Assistant Director-General

Family, Women's and Children's Health (FWC)


Ms Hannah Sarah Faich Project Officer



Dr Martin Howell Friede Scientist



Dr Keiji Fukuda Assistant Director-General

Health Security and Environment (HSE)


15 July 2011

21

Dr Joachim Maria Hombach Scientist



Dr Shafiqul Hossain Technical Officer

Expanded Programme on Immunization

Regional Office for the Western Pacific (WPRO)

Manila, Philippines

Mrs Anne Marie Huvos Technical Officer



Dr Marie-Paule Kieny Assistant Director-General



Dr Jayantha Bandula L. Liyanage Medical Officer

SE/VPD Vaccine Preventable Diseases

Regional Office for South-East Asia (SEARO)

New Delhi, India

Dr Rebecca Mae Martin Medical Officer

EU/CDS Communicable Diseases

Regional Office for Europe (EURO)

Copenhagen, Denmark

Ms Stefanie Meredith Meeting Rapporteur

Global Health Consulting

Dr Anthony Wayne Mounts Medical Officer

Disease Monitoring, Assessment and Control/Health Security and Environment (HSE)


Dr Richard Mihigo Medical Officer

Immunization Vaccines Development

Regional Office for Africa (AFRO)

Brazzaville, Congo

15 July 2011

22

Dr Faith McLellan Information Manager



Dr Pem Namgyal Scientist



Dr Jean-Marie Okwo-Bele Director

Immunization, Vaccines and Biologicals (IVB)


Dr Laszlo Palkonyay Medical Officer

Immunization, Vaccines and Biologicals/ Quality, Safety and Standards (IVB/QSS)


Mr James Pfitzer III Technical Officer



Dr Alba Maria Ropero Alvarez Medical Officer

Immunization Unit

Regional Office for the Americas (AMRO)

Washington DC, USA

Dr Cathy Ellen Roth Medical Officer

Biorisk Reduction for Dangerous Pathogens/Health Security and Environment (HSE)


Mrs Dalia Samhouri Technical Officer

EM/DCD Division of Communicable Disease Control

Regional Office for the Eastern Mediterranean (EMRO)

Cairo, Egypt

Dr Natasha Shapovalova Technical Officer



15 July 2011

23

Ms Erin Grace Sparrow Project Officer



Dr Siu Lun (John)Tam Technical Officer



Mr Guido Torelli Administrative Officer



Dr Tony Waddell Meeting Rapporteur

9 Sidney Close, Stanley, Co Durham, DH9 6UH


Dr David Wood Coordinator

Immunization, Vaccines and Biologicals/ Quality, Safety and Standards (IVB/QSS)


Documents

SECOND WHO CONSULTATION ON A GLOBAL ACTION PLAN FOR